Insmed Incorporated (INSM) — Financial statements
Income statement, balance sheet, and cash flow for Insmed Incorporated — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 606↑66.7% | 364↑19.2% | 305↑24.4% | 245↑30.2% | 188 | |
| Cost of Revenue | 125↑45.6% | 86↑30.8% | 66↑19.0% | 55↑24.9% | 44 | |
| Gross Profit | 482↑73.2% | 278↑16.0% | 240↑26.0% | 190↑31.8% | 144 | |
| Operating Expenses | ||||||
| R&D Expenses | 771↑28.9% | 598↑4.8% | 571↑43.6% | 398↑45.7% | 273 | |
| General & Administrative Expenses | 701↑52.1% | 461↑33.9% | 345↑29.6% | 266↑13.5% | 234 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 701↑52.1% | 461↑33.9% | 345↑29.6% | 266↑13.5% | 234 | |
| Other Expenses | 186↑92.3% | 97↑186.6% | 34↑314.3% | -16↓227.2% | 12 | |
| Operating Expenses | 1,658↑43.4% | 1,156↑21.8% | 949↑46.6% | 648↑24.7% | 519 | |
| Total Costs & Expenses | 1,783↑43.6% | 1,242↑22.4% | 1,015↑44.4% | 703↑24.7% | 564 | |
| Operating Results | ||||||
| Operating Income | -1,177↓34.0% | -878↓23.8% | -710↓55.2% | -457↓21.9% | -375 | |
| Depreciation & Amortization | 16↑49.4% | 11↑4.1% | 11↑2.4% | 10↓27.2% | 14 | |
| EBITDA | -1,172↓43.1% | -819↓24.0% | -660↓47.6% | -447↓16.6% | -384 | |
| EBIT | -1,188↓43.2% | -830↓23.7% | -671↓46.6% | -458↓15.0% | -398 | |
| Interest & Other Income | ||||||
| Net Interest Income | -23↑26.8% | -32↑20.1% | -40↓157.5% | -15↑61.9% | -40 | |
| Interest Income | 61↑13.8% | 53↑26.5% | 42↑280.2% | 11↑6268.4% | 0.17 | |
| Interest Expense | 84↓1.3% | 85↑3.9% | 82↑208.9% | 26↓34.7% | 40 | |
| Non-Operating Income | 11↑123.2% | -48↓24.6% | -39↓10465.3% | 0.38↓98.4% | 23 | |
| Other Income / Expenses | -95↓198.7% | -32↑14.9% | -37↓63.8% | -23↑62.8% | -61 | |
| Income Before Tax | -1,272↓39.7% | -910↓21.8% | -747↓55.6% | -480↓10.0% | -436 | |
| Income Tax Expense | 5↑35.6% | 4↑45.1% | 3↑84.7% | 1↑178.7% | -2 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -1,277↓39.7% | -914↓21.9% | -750↓55.7% | -482↓10.8% | -435 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -1,277↓39.7% | -914↓21.9% | -750↓55.7% | -482↓10.8% | -435 | |
| Bottom-Line Net Income | -1,277↓39.7% | -914↓21.9% | -750↓55.7% | -482↓10.8% | -435 | |
| EPS (Basic) | -6.41↓15.1% | -5.57↓4.3% | -5.34↓36.6% | -3.91↓0.8% | -3.88 | |
| EPS (Diluted) | -6.41↓15.1% | -5.57↓4.3% | -5.34↓36.6% | -3.91↓0.8% | -3.88 | |
| Weighted Average Shares | 214↑30.2% | 164↑16.8% | 140↑14.1% | 123↑9.7% | 112 | |
| Weighted Average Diluted Shares | 214↑30.2% | 164↑16.8% | 140↑14.1% | 123↑9.7% | 112 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.